GeneDx plans to launch long-read whole genome sequencing for rare disease testing, with an early access program expected by ...
Ultima Genomics introduces paired-end sequencing and Solaris 2.0 Max consumables, enabling $60 genome and doubling output.
CDC reports early-season influenza activity is above average for November, with H1N1 dominating lab detections.
BillionToOne will launch Northstar Clear, a tissue-free MRD test for all solid tumors, on Dec 15, 2026, according to a ...
Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...
FDA grants Breakthrough Device Designation to Primaa’s Cleo Skin AI pathology tool, which now has both CE-IVDR and FDA status ...
New England Biolabs will present new multiomic cell-free DNA and RNA workflows, enzymatic methylation profiling, and a PCR ...
Labcorp has completed its acquisition of Millennium Health, expanding its national toxicology testing network.
Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.
Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...
Hepta reports its AI-based blood test matched MRE in identifying treatment-eligible MASH fibrosis in an independent Madrigal ...
A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results